Less Ads, More Data, More Tools Register for FREE

Pin to quick picksClose Bros Regulatory News (CBG)

Share Price Information for Close Bros (CBG)

Share Price is delayed by 15 minutes
Get Live Data
407.00    0.80 (0.20%)
Bid:
405.00
Ask:
405.40
Spread: 0.40 (0.099%)
Market Cap: £613.40m
CBG Live PriceLast checked at - London Stock Exchange

Intraday Close Bros Share Chart

Scheduled Trading Update

22 Jan 2019 07:00

RNS Number : 6874N
Close Brothers Group PLC
22 January 2019
 

 

Scheduled Trading Update

Close Brothers Group plc ("the group" or "Close Brothers") today issues its scheduled pre-close trading update ahead of its 2019 half year end. Close Brothers will be releasing its half year results for the six months ending 31 January 2019 on 12 March 2019.

All statements in this release relate to continuing operations1 over the five months to 31 December 2018 unless otherwise indicated.

Group and divisional performance

The group has achieved a solid performance overall, notwithstanding the difficult trading conditions for our market facing businesses.

The Banking division has continued to perform well and in line with expectations, as we focus on maintaining our disciplined approach to lending and investing to maximise the long-term potential of our businesses.

The loan book grew 3.1% in the period to £7.5 billion (1 August 2018: £7.2 billion2), driven by good new business volumes across the Commercial businesses and in Premium Finance.

Impairment charges remained low, with strong credit performance across all businesses. The net interest margin has remained broadly stable since the last financial year, reflecting our continued pricing discipline.

Winterflood has continued to deliver solid profitability, but volumes and trading income have been significantly lower than the prior year reflecting difficult and volatile equity market conditions, particularly in December.

Asset Management has continued to achieve good net inflows, although these were more than offset by negative market movements, resulting in a 3% decline in managed assets to £10.0 billion at 31 December 2018 (31 July 2018: £10.4 billion) and a decrease in total client assets to £11.7 billion (31 July 2018: £12.2 billion).

Outlook

Overall, we expect a solid outcome for the first half, and remain well positioned for the remainder of the financial year.

 

1 Results from continuing operations exclude the unsecured retail point of sale finance business, which was classified as a discontinued operation in the group's 2018 financial statements.

2 The opening net loan book of £7,239 million reflects the adoption of IFRS 9 at 1 August 2018. For further details see the group's IFRS 9 transition document published on 7 November 2018.

 

 

Enquiries

 

Sophie Gillingham

Close Brothers Group plc

020 7655 3844

Matt Bullivant

Close Brothers Group plc

020 7655 3698

Declan Simpson

Close Brothers Group plc

020 7655 3632

Andy Donald

Maitland

020 7379 5151

 

About Close Brothers

Close Brothers is a leading UK merchant banking group providing lending, deposit taking, wealth management services and securities trading. We employ around 3,300 people, principally in the UK. Close Brothers Group plc is listed on the London Stock Exchange and is a member of the FTSE 250.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTCKDDPABKDNDB
Date   Source Headline
1st Dec 20214:01 pmRNSTransaction in Own Shares
30th Nov 20213:23 pmRNSTotal Voting Rights
29th Nov 202112:07 pmRNSTransaction in Own Shares
25th Nov 20215:50 pmRNSDirector/PDMR Shareholding
22nd Nov 20212:00 pmRNSTransaction in Own Shares
18th Nov 20213:01 pmRNSResult of AGM
18th Nov 20213:01 pmRNSAGM Special Business
18th Nov 20217:02 amRNSCBAM Management Change
18th Nov 20217:00 amRNSScheduled Trading Update
15th Nov 20212:00 pmRNSTransaction in Own Shares
8th Nov 20212:46 pmRNSDirector/PDMR Shareholding
8th Nov 202110:30 amRNSHolding(s) in Company
4th Nov 20214:45 pmRNSHolding(s) in Company
3rd Nov 20215:12 pmRNSShare Purchase
2nd Nov 20215:44 pmRNSShare Purchase
1st Nov 20215:20 pmRNSShare Purchase
1st Nov 202111:30 amRNSTransaction in Own Shares
29th Oct 20215:54 pmRNSTotal Voting Rights
29th Oct 20215:50 pmRNSShare Purchase
28th Oct 20215:42 pmRNSShare Purchase
27th Oct 20215:52 pmRNSShare Purchase
26th Oct 20216:10 pmRNSShare Purchase
26th Oct 202110:51 amRNSHolding(s) in Company
26th Oct 20219:00 amRNSShare Purchase
25th Oct 202110:35 amRNSTransaction in Own Shares
20th Oct 20215:30 pmRNSHolding(s) in Company
19th Oct 20213:24 pmRNSDirector/PDMR Shareholding
15th Oct 20214:25 pmRNSDirector/PDMR Shareholding
15th Oct 20219:40 amRNSNotice of Quarterly Trading Update
14th Oct 20214:37 pmRNSDirector/PDMR Shareholding
14th Oct 20219:00 amRNSAGM Documents
12th Oct 20212:10 pmRNSHolding(s) in Company
11th Oct 20219:46 amRNSTransaction in Own Shares
7th Oct 20215:16 pmRNSDirector/PDMR Shareholding
6th Oct 20215:22 pmRNSDirector/PDMR Shareholding
6th Oct 20213:25 pmRNSDirector/PDMR Shareholding
4th Oct 20215:33 pmRNSHolding(s) in Company
4th Oct 20214:54 pmRNSPillar 3 disclosures for year ended 31 July 2021
4th Oct 20214:34 pmRNSAnnual Financial Report
4th Oct 202110:03 amRNSTransaction in Own Shares
30th Sep 20213:55 pmRNSTotal Voting Rights
28th Sep 20217:00 amRNSPreliminary Results for the year ended 31 July 21
20th Sep 20212:00 pmRNSTransaction in Own Shares
7th Sep 20214:19 pmRNSDirector/PDMR Shareholding
31st Aug 20211:40 pmRNSTotal Voting Rights
23rd Aug 202110:17 amRNSTransaction in Own Shares
16th Aug 202111:09 amRNSTransaction in Own Shares
6th Aug 202112:34 pmRNSDirector/PDMR Shareholding
2nd Aug 20219:03 amRNSTransaction in Own Shares
30th Jul 202111:47 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.